Metagenomi Therapeutics Announces FDA Clearance Of Investigational New Drug Application For Mgx-001 And Reports Third Quarter 2026 Financial
Metagenomi Therapeutics Inc NASDAQ:MGX
Related stories
Modi’s Office Summons Telecom Secretary Over Website Takedowns
Government sources say the summons follows Reuters revelations that website takedowns were based on fake court orders.
M impact | REGULATION | Nov 14, 2026, 07:58 AM UTC
China Says Both Sides Discussed Reciprocal Tariff Cuts Worth $30 Billion Each
China’s Commerce Ministry said the sides discussed tariffs, reciprocal tariff cuts worth $30 billion on each side, agricultural trade and other issues.
L impact | REGULATION | Nov 14, 2026, 06:56 AM UTC
China to Add Pfizer GLP-1 Drug to State Health Insurance Scheme
M impact | REGULATION | Nov 14, 2026, 06:02 AM UTC
China to Add JW Therapeutics’ CAR-T Therapy to State Insurance
China’s National Healthcare Security Administration says JW Therapeutics’ CAR-T therapy will be added to the state-run health insurance scheme.
L impact | REGULATION | Nov 14, 2026, 03:03 AM UTC
China to Add JW Therapeutics CAR-T Therapy to State Health Insurance
China's National Healthcare Security Administration says JW Therapeutics' CAR-T therapy will be added to the state-run health insurance scheme.
M impact | REGULATION | Nov 14, 2026, 03:03 AM UTC
Trump Administration Seeks $50 Billion for Air Traffic Control After Outage
The administration boosted its request for air traffic control funding to $50 billion after a communications issue forced a nationwide groundstop, halting thousands of flights for
M impact | REGULATION | Nov 14, 2026, 02:44 AM UTC